MYDX - MyDx, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0004
-0.0001 (-10.00%)
At close: 2:57PM EDT
Stock chart is not supported by your current browser
Previous Close0.0005
Open0.0004
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0004 - 0.0004
52 Week Range0.0003 - 0.0030
Volume2,107,668
Avg. Volume16,750,064
Market Cap1.832M
Beta (3Y Monthly)-3.58
PE Ratio (TTM)N/A
EPS (TTM)-0.0020
Earnings DateApr 25, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire

    MyDx Announces Letter to Shareholders

    SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, today issued a press release with the following letter to shareholders. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements.

  • GlobeNewswire

    MyDx Announces 2018 Fiscal Year Results and Shareholder Update

    SAN DIEGO, CA, April 25, 2019 -- via NEWMEDIAWIRE – MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, announced that it has filed its 2018 10-K.

  • GlobeNewswire

    MYDX RECRUITS MR. CANNABIS GROUP TO OPERATE COMPANY

    MyDx, Inc. (OTC: MYDX) (the “Company”), a leader in science based cannabis health technologies, is proud to announce that it has successfully recruited the Mr. Cannabis Group to operate the Company effective immediately. Mr. Beckmann is an accomplished thought leader and influencer in the southern California cannabis industry, and is recognized as “Mr. Cannabis”.  In 2015, Erai helped federally legalize medical THC and CBD in the country of Brazil.  Since then, he has advised major pharma groups to help them with their global CBD R&D efforts.  As a result of his work with big pharma, and his own cannabis lobbying experience in Latin America, he co-founded Humanity, Inc., which believes it will produce the world’s first nootropics-infused microdosed cannabis pill.

  • MyDx Analyzer to be Used in Large HIV Study by the University of Florida
    Newsfile

    MyDx Analyzer to be Used in Large HIV Study by the University of Florida

    San Diego, California--(Newsfile Corp. - September 28, 2018) - MyDx, Inc. (OTC Pink: MYDX), a leader in science based cannabis health technologies, is proud to announce that the University of Florida will be using our flagship product, the CannaDx Analyzer, in the largest prospective study to date focused on the health effects of marijuana in people living with HIV.MyDx Analyzer to be Used in Large HIV Study Please visit http://orders.newsfilecorp.com/files/6086/38974_a1538137879405_91.jpg to view this image"With this study, we ...

  • Newsfile

    MyDx Shareholder Update

    A Leader in Science-Based Cannabis Health Technologies Positioning for a Pharma Acquisition San Diego, California--(Newsfile Corp. - September 21, 2018) - MyDx, Inc. (OTC Pink: MYDX), a leader in science-based cannabis health technologies, has been working diligently over the past four months on implementing a strategy designed to have it become a highly desired acquisition target for big pharma or another entity interested in the powerful data MyDx is accumulating in the emerging global ...

  • Newsfile

    MyDx Announces 2018 First Quarter Results

    MyDx Reports Positive Net Income as it Positions Itself for Growth and Investment San Diego, California--(Newsfile Corp. - September 19, 2018) - MyDx, Inc. (OTC Pink: MYDX), a leader in science based cannabis health technologies and creator of the industry's first handheld analyzer to help consumers and professionals understand how cannabis makes cannabis users feel,today announces its 2018 first quarter earnings results and management analysis.MyDx reported positive earnings of $880k in the first quarter of 2018 as it ...

  • MyDx Secures City and State Legal Cannabis Manufacturing and Distribution for Its MyDx360 Customers
    Newsfile

    MyDx Secures City and State Legal Cannabis Manufacturing and Distribution for Its MyDx360 Customers

    MyDx360 Customers in California Now Have Access to One of the First Legally Licensed Cannabis Manufacturing and Distribution Facilities Located in the City of San Diego San Diego, California--(Newsfile Corp. - September 19, 2018) - MyDx, Inc. (OTC Pink: MYDX) ("MyDx" or the "Company"), a leader in science based cannabis health technologies and creator of the industry's first handheld, multi-use chemical analyzer to help consumers and professionals understand how cannabis makes cannabis users feel, announced ...

  • Newsfile

    Dr. Heiner Dreismann, Former CEO of Roche Molecular Systems and Diagnostics Veteran, Joins MyDx Executive Advisory Board

    Dr. Dreismann To Also Serve as Chairman of the Executive Advisory Board; Assist MyDx In Seeking Development Partners and Strategic Partners San Diego, California--(Newsfile Corp. - September 19, 2018) - MyDx, Inc. (OTC Pink: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for Cannabis professionals and retail consumers to understand the chemical profile of cannabis with how it makes them feel and which ailments it ...

  • Newsfile

    MyDx Announces 2017 Fiscal Year Results

    Gross Profit Margin Surged to 73% with Gross Profits Remaining Relatively Flat at ~$306K as MyDx Continues to Execute on its Long-Term Strategy San Diego, California--(Newsfile Corp. - September 19, 2018) - MyDx, Inc. (OTC Pink: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for Cannabis professionals and retail consumers to correlate the chemical profile of cannabis with how it makes them feel and which ailments ...